We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $46.3B
1-Year Est. Return 43.9%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$39.9B
AUM Growth
-$3.99B
Cap. Flow
-$1.18B
Cap. Flow %
-2.97%
Top 10 Hldgs %
37.22%
Holding
1,874
New
146
Increased
562
Reduced
366
Closed
20

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$543M
2
NVDA icon
NVIDIA
NVDA
+$373M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$178M
4
ABBV icon
AbbVie
ABBV
+$149M
5
MSFT icon
Microsoft
MSFT
+$146M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$598M
2
NFLX icon
Netflix
NFLX
+$259M
3
JNJ icon
Johnson & Johnson
JNJ
+$239M
4
AMZN icon
Amazon
AMZN
+$217M
5
V icon
Visa
V
+$175M

Sector Composition

Rank Sector Weight
1 Technology 37.27%
2 Financials 12.41%
3 Healthcare 11.52%
4 Communication Services 10.2%
5 Industrials 8.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRI icon
1751
Carter's
CRI
$1.47B
$36K ﹤0.01%
1,007
– –
STOK icon
1752
Stoke Therapeutics
STOK
$2.06B
$36K ﹤0.01%
+1,096
New +$35.9K
TNET icon
1753
TriNet
TNET
$3.14B
$36K ﹤0.01%
993
– –
CDNA icon
1754
CareDx
CDNA
$2.35B
$35K ﹤0.01%
2,018
-1,508
-43% -$28.5K
CSR
1755
Centerspace
CSR
$956M
$35K ﹤0.01%
614
– –
DHC
1756
Diversified Healthcare Trust
DHC
$2.22B
$35K ﹤0.01%
+5,276
New +$33.5K
FA icon
1757
First Advantage
FA
$3.53B
$35K ﹤0.01%
+2,979
New +$36.4K
HCSG icon
1758
Healthcare Services Group
HCSG
$1.57B
$35K ﹤0.01%
+1,882
New +$37.1K
MNKD icon
1759
MannKind Corp
MNKD
$1.31B
$35K ﹤0.01%
14,348
– –
MXL icon
1760
MaxLinear
MXL
$6.12B
$35K ﹤0.01%
+1,999
New +$35.9K
USAR
1761
USA Rare Earth Inc
USAR
$4.2B
$35K ﹤0.01%
+2,309
New +$44.8K
DCH
1762
Dauch Corp
DCH
$1.42B
$34K ﹤0.01%
+5,779
New +$40.2K
ENVX icon
1763
Enovix
ENVX
$936M
$34K ﹤0.01%
6,514
– –
FIVN icon
1764
FIVE9
FIVN
$2.28B
$34K ﹤0.01%
2,261
– –
GSHD icon
1765
Goosehead Insurance
GSHD
$2.38B
$34K ﹤0.01%
799
– –
IOVA icon
1766
Iovance Biotherapeutics
IOVA
$1.94B
$34K ﹤0.01%
+9,586
New +$30.7K
KNSA icon
1767
Kiniksa Pharmaceuticals
KNSA
$6.09B
$34K ﹤0.01%
+706
New +$31.3K
NRIX icon
1768
Nurix Therapeutics
NRIX
$2.61B
$34K ﹤0.01%
+2,192
New +$36.3K
OUST icon
1769
Ouster
OUST
$3.04B
$34K ﹤0.01%
1,840
– –
PRA
1770
DELISTED
ProAssurance
PRA
$34K ﹤0.01%
1,356
– –
RLAY icon
1771
Relay Therapeutics
RLAY
$4.29B
$34K ﹤0.01%
+3,448
New +$30.8K
SEB icon
1772
Seaboard Corp
SEB
$4.12B
$34K ﹤0.01%
+6
New +$30.1K
VRDN icon
1773
Viridian Therapeutics
VRDN
$2.33B
$34K ﹤0.01%
+1,737
New +$51.6K
ASTH icon
1774
Astrana Health
ASTH
$1.77B
$34K ﹤0.01%
1,402
– –
CCOI icon
1775
Cogent Communications
CCOI
$644M
$33K ﹤0.01%
1,761
– –
69 70
71
72 73

Similar funds

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $46B AUM 27.59% 1-Year Est. Return
Wealthfront Advisers
Wealthfront Advisers Palo Alto, California $45.6B AUM 18.83% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return
TI
Tidal Investments Milwaukee, Wisconsin $47.4B AUM 59.58% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $47.7B AUM 29.41% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

KBC Group's Q1 2026 Portfolio in Review

As of Q1 2026, KBC Group held 1,874 positions worth $39.9B, down 9.1% from $43.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

KBC Group's Q1 2026 filing shows 146 new, 562 increased, 366 reduced and 20 closed positions. Its largest new stake was AbbVie: 669,647 shares worth $146M. The largest sale was Alphabet (Google) Class C, an estimated $598M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

  • KBC Group's largest Q1 2026 buy was AbbVie: 669,647 shares worth $146M.
  • KBC Group added most to Apple in Q1 2026, an estimated $543M increase.
  • KBC Group's biggest Q1 2026 reduction was Alphabet (Google) Class C, cutting an estimated $598M.
  • KBC Group fully exited CyberArk in Q1 2026, selling an estimated $6.81M.
  • KBC Group's ten largest holdings make up 37% of its $39.9B portfolio in Q1 2026.
  • KBC Group opened 146 new positions and closed 20 in Q1 2026.
  • KBC Group's portfolio value fell 9.1% quarter-over-quarter to $39.9B.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.